Acer Therapeutics Inc.
NASDAQ:ACER
0.9 (USD) • At close July 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 1.26 | 0 | 0 | 0.432 | -0.246 | 2.905 | 2.556 | 1.272 | 1.267 | 0 | 0 | 0 | 0 | 0 | 0.046 | 0.046 | 0 | 0 | 0.004 | 0.016 | 0.25 | 0.816 | 2.902 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.266 | 0.688 | 2.539 |
| Gross Profit
| 0 | 1.26 | 0 | 0 | 0.432 | -0.246 | 2.905 | 2.556 | 1.272 | 1.267 | 0 | 0 | 0 | 0 | 0 | 0.046 | 0.046 | 0 | 0 | 0.004 | 0.016 | -0.016 | 0.129 | 0.363 |
| Gross Profit Ratio
| 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | -0.066 | 0.158 | 0.125 |
| Reseach & Development Expenses
| 11.925 | 6.508 | 11.848 | 13.851 | 12.452 | 8.725 | 6.498 | 10.039 | 12.119 | 9.181 | 6.318 | 3.34 | 2.585 | 2.108 | 8.389 | 13.072 | 7.613 | 9.892 | 0.633 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.689 | 10.7 | 10.955 | 16.046 | 9.261 | 5.223 | 3.122 | 4.258 | 3.833 | 3.671 | 2.509 | 0 | 2.216 | 2.021 | 0 | 0 | 5.461 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.689 | 10.7 | 10.955 | 16.046 | 9.261 | 5.223 | 3.122 | 4.258 | 3.833 | 3.671 | 2.509 | 2.406 | 2.216 | 2.021 | 3.341 | 3.418 | 5.461 | 0.55 | 3.127 | 0.12 | 0.13 | 0.528 | 0.976 | 0.686 |
| Other Expenses
| -1.72 | 0 | 0 | 0 | 0 | 0 | 0.011 | 0.069 | 0.002 | 0.038 | 0.304 | 0.22 | 0.169 | 0.217 | 0.237 | 0.246 | 1.821 | 1.758 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 24.614 | 17.208 | 22.803 | 29.897 | 21.713 | 13.948 | 9.858 | 14.649 | 16.34 | 13.187 | 9.131 | 5.966 | 4.97 | 4.345 | 11.967 | 16.736 | 14.895 | 12.2 | 3.76 | 0.122 | 0.16 | 0.528 | 0.976 | 0.73 |
| Operating Income
| -24.614 | -15.948 | -22.803 | -29.897 | -21.713 | -13.948 | -7.992 | -12.094 | -15.068 | -11.923 | -9.134 | -5.965 | -4.97 | -4.345 | -11.967 | -16.736 | -14.895 | -12.2 | -3.76 | -0.118 | -0.144 | -0.545 | -0.847 | -0.367 |
| Operating Income Ratio
| 0 | -12.657 | 0 | 0 | -50.248 | 56.63 | -2.751 | -4.731 | -11.847 | -9.413 | 0 | 0 | 0 | 0 | 0 | -360.308 | -320.671 | 0 | 0 | -30.121 | -8.987 | -2.183 | -1.038 | -0.127 |
| Total Other Income Expenses Net
| -1.623 | 0.574 | -0.083 | 0.479 | 0.021 | -0.016 | -1.028 | 0.068 | 0.002 | -2.483 | 0.55 | -0.003 | -0.499 | 3.187 | 0.032 | 1.594 | 0.149 | 0.005 | 0.002 | 0.085 | -0.018 | 0.002 | -0 | 0.203 |
| Income Before Tax
| -26.237 | -15.374 | -22.885 | -29.418 | -21.281 | -14.194 | -7.98 | -12.019 | -15.052 | -16.656 | -8.931 | -5.968 | -5.469 | -1.434 | -11.852 | -14.667 | -14.056 | -19.414 | -4.621 | -0.033 | -0.162 | -0.542 | -0.847 | -0.164 |
| Income Before Tax Ratio
| 0 | -12.202 | 0 | 0 | -49.248 | 57.63 | -2.747 | -4.702 | -11.835 | -13.15 | 0 | 0 | 0 | 0 | 0 | -315.767 | -302.614 | 0 | 0 | -8.309 | -10.096 | -2.173 | -1.038 | -0.057 |
| Income Tax Expense
| 1.623 | -0.645 | 0.012 | -0.538 | -0.432 | 0.246 | 1.038 | -0.005 | 0.004 | 2.305 | -0.203 | 5.968 | 5.469 | 1.434 | 11.852 | 14.667 | 14.056 | 19.414 | 4.621 | -0.03 | 0.055 | 0.053 | 0.034 | -0.189 |
| Net Income
| -27.86 | -14.729 | -22.897 | -28.88 | -21.281 | -14.194 | -7.98 | -12.019 | -15.052 | -16.656 | -8.931 | -5.968 | -5.469 | -1.434 | -11.852 | -14.667 | -14.056 | -19.414 | -4.621 | -0.088 | -0.199 | -0.598 | -0.881 | -0.178 |
| Net Income Ratio
| 0 | -11.689 | 0 | 0 | -49.248 | 57.63 | -2.747 | -4.702 | -11.835 | -13.15 | 0 | 0 | 0 | 0 | 0 | -315.767 | -302.614 | 0 | 0 | -22.372 | -12.408 | -2.395 | -1.079 | -0.061 |
| EPS
| -1.77 | -1.03 | -2.06 | -2.86 | -2.49 | -3.84 | -11.72 | -21.26 | -39.65 | -91.56 | -113.13 | -77.65 | -93.91 | -33.48 | -329.28 | -642.07 | -764.35 | -363.69 | -2,147.15 | -385.85 | -4,857.44 | -13,900.98 | -18,348.92 | -3,792.51 |
| EPS Diluted
| -1.77 | -1.03 | -2.06 | -2.86 | -2.49 | -3.84 | -11.72 | -21.26 | -39.65 | -91.56 | -113.13 | -77.65 | -93.91 | -33.48 | -329.28 | -642.07 | -764.35 | -363.69 | -2,147.15 | -385.85 | -4,857.44 | -13,900.98 | -18,348.92 | -3,792.51 |
| EBITDA
| -24.813 | -16.003 | -22.707 | -29.906 | -21.3 | -13.933 | -5.676 | -11.74 | -14.663 | -11.532 | -8.827 | -5.756 | -4.801 | -7.318 | -11.765 | -18.098 | -13.225 | -4.954 | -2.744 | -0.202 | -0.113 | -0.532 | -0.827 | -0.551 |
| EBITDA Ratio
| 0 | -12.701 | 0 | 0 | -49.293 | 56.569 | -1.954 | -4.593 | -11.528 | -9.105 | 0 | 0 | 0 | 0 | 0 | -389.615 | -284.724 | 0 | 0 | -51.553 | -7.071 | -2.131 | -1.014 | -0.19 |